Original Article | NRJIM Vol. 1, Issue 1, pp. 26 to 32, May-June 2026
Dr. Raghwendra Singh, Dr. (Prof.) Ajay Kumar Singh, Dr. Usha Mishra
ABSTRACT
The disease Amavata i.e. Rheumatoid arthritis is a challenge for the physician because of its apparent chronicity, incurability, complications, morbidity and crippling nature. About 0.5-1% of the world’s population suffers from Rheumatoid arthritis (Harrison 2017). Rheumatoid arthritis has generated universal interest among research scholars around the world. Many efforts have been made at this institute and other research centers to study different aspects of Amavata. The present study conducted clinical trials on Amavata. Till date no satisfactory treatment has been available for Amavata disease. The main objective of the treatment of this disease is to provide relief in the form of reduced pain and discomfort, prevention of further disease process, loss of joint function, maintaining productive and active life and above all to restore the vitality of the body (oja) or a good immune status. In this study the medicine Simhanada Guggulu is used against the Amavata where analysis of efficacy will be determined.
KEYWORDS: Amavata, Rheumatoid arthritis, Simhanada Guggulu